Company
HanchorBio
Reimagining Immunotherapy for Patients Worldwide
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- 臺北, Taiwan
- Founded
- 2020
- hanchorbio.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
漢康生技成立於2020年底，專注於癌症及自體免疫疾病的新藥開發。自成立以來，率先以FBDB™技術平台開創精準的腫瘤治療模式。透過獨特的藥物設計與臨床策略，推動癌症治療邁向更有效與安全的新時代。
Products
- Other
- HCB101
- Other
- HCB301
- Other
- HCB303
Loading relationship preview